Latest News
NeuroOne Medical Technologies Corporation
- NeuroOne secures first pharma order for drug delivery platform By Investing.com
- NeuroOne lands first pharma order for StereoCED™ drug delivery platform in major commercial milestone
- NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
- NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
- NeuroOne Medical (NMTC) Stock Forum and Discussion
- NeuroOne receives $200,000 NIH subaward through April 2027
- NeuroOne Medical Technologies (NasdaqCM:NMTC) Stock Forecast & Analyst Predictions
- NeuroOne NMTC Expects $3.8 Million Fiscal Q4 Product Revenue
- NeuroOne Reports Preliminary Fiscal Q4 and Full-Year 2026 Product Revenue Growth, Tops Guidance with Record $4.5 Million Order
- NeuroOne reports preliminary Q4 revenue of $3.8 million
Headlines from the last 30 days, linking to the original publishers. See all market news →